Hospital
Harford Memorial Hospital, INC.
Harford Memorial Hospital, INC. was paid $2.03M by Medicaid between Jan 2018 and Jan 2024, across 46 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 67% of everything it billed.
33Billing provider infoHARFORD MEMORIAL HOSPITAL, INC.
HAVRE DE GRACE, MD 21078
HAVRE DE GRACE, MD 21078
33aNPI1770589533assigned 06/24/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.03M
24GClaims31,146
24DCodes billed46
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#20 of 69
Median peer was paid$870K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRIOLO, MARCUS controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,536 | $673K | |
| 2019 | 7,779 | $818K | |
| 2020 | 3,583 | $120K | |
| 2021 | 5,089 | $170K | |
| 2022 | 3,739 | $116K | |
| 2023 | 3,210 | $120K | |
| 2024incomplete | 210 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 67% | 231 | 221 | $1.36M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 2,739 | 2,448 | $298K |
| G0378 | Hospital observation service, per hour | 5.7% | 416 | 369 | $116K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.0% | 1,530 | 1,392 | $102K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.4% | 2,028 | 1,666 | $89K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.4% | 241 | 228 | $49K |
| 80053 | Comprehensive metabolic panel | <1% | 3,805 | 3,099 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 639 | 586 | $3K |
| 93793 | <1% | 178 | 100 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,092 | 871 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,521 | 3,328 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 490 | 440 | $940.90 |
34 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 83 | $826.39 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,299 | $583.47 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 22 | $484.63 |
| 84484 | <1% | 1,564 | $434.31 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 482 | $392.83 |
| 96127 | <1% | 104 | $250.10 | |
| 81001 | <1% | 859 | $233.45 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 623 | $205.22 |
| 83735 | <1% | 2,341 | $191.51 | |
| 83690 | <1% | 685 | $133.33 | |
| 85610 | <1% | 1,168 | $105.61 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 580 | $95.86 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $85.11 |
| 84703 | <1% | 72 | $42.94 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 724 | $32.92 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 62 | $31.88 |
| 81003 | <1% | 192 | $31.54 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 57 | $30.41 |
| 82150 | <1% | 270 | $19.65 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 81 | $14.82 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 65 | $12.08 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 385 | $10.56 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 345 | $7.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 178 | $1.84 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 87 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 39 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 27 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 14 | $0.00 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 0% | 18 | $0.00 |
| 85730 | 0% | 18 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 661 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 55 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 16 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRIOLO, MARCUS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upper Chesapeake Medical Services, INC | Bel Air, MD | $2.91M |
| Upper Chesapeake Medical Center, INC. | Bel Air, MD | $1.57M |
| Harford Primary Care LLC | Bel Air, MD | $880K |
| Upper Chesapeake Cardiology, LLC | Bel Air, MD | $565K |
| Upper Chesapeake Primary Care,llc | Bel Air, MD | $480K |
| Upper Chesapeake Womens Care, LLC | Bel Air, MD | $459K |
| Upper Chesapeake Medical Services, INC. | Aberdeen, MD | $363K |
| Upper Chesapeake Hematology and Oncology Services, LLC | Bel Air, MD | $184K |
| Harford Crisis Center, INC. | Bel Air, MD | $116K |
| Upper Chesapeake Endocrinology Associates, LLC | Aberdeen, MD | $106K |
| Upper Chesapeake Orthopedics, LLC | Bel Air, MD | $75K |
| Upper Chesapeake Surgical Associates, LLC | Bel Air, MD | $53K |
| Upper Chesapeake Critical Care Associates, LLC | Bel Air, MD | $52K |
| Harford Crisis Center, INC. | Bel Air, MD | $37K |
| Upper Chesapeake Radiation Oncology, LLC | Aberdeen, MD | $11K |
| Upper Chesapeake Medical Center, INC. | Aberdeen, MD | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.